Your browser is no longer supported. Please, upgrade your browser.
Settings
LLY Eli Lilly and Company daily Stock Chart
LLY [NYSE]
Eli Lilly and Company
IndexS&P 500 P/E66.62 EPS (ttm)1.68 Insider Own11.20% Shs Outstand1.05B Perf Week1.30%
Market Cap117.40B Forward P/E19.38 EPS next Y5.78 Insider Trans-3.38% Shs Float1.05B Perf Month5.52%
Income1.77B PEG5.86 EPS next Q1.36 Inst Own79.20% Short Float0.90% Perf Quarter25.92%
Sales23.87B P/S4.92 EPS this Y-37.00% Inst Trans-0.21% Short Ratio2.28 Perf Half Y39.55%
Book/sh11.22 P/B9.98 EPS next Y5.56% ROA-0.30% Target Price110.07 Perf Year29.60%
Cash/sh6.59 P/C16.99 EPS next 5Y11.38% ROE-1.10% 52W Range73.69 - 116.61 Perf YTD32.51%
Dividend2.25 P/FCF56.35 EPS past 5Y-15.00% ROI6.60% 52W High-4.02% Beta0.28
Dividend %2.01% Quick Ratio1.10 Sales past 5Y0.20% Gross Margin72.90% 52W Low51.88% ATR2.22
Employees40655 Current Ratio1.40 Sales Q/Q9.10% Oper. Margin9.10% RSI (14)56.45 Volatility1.91% 1.84%
OptionableYes Debt/Eq1.06 EPS Q/Q-126.50% Profit Margin-0.60% Rel Volume1.01 Prev Close113.31
ShortableYes LT Debt/Eq0.79 EarningsNov 06 BMO Payout- Avg Volume4.15M Price111.92
Recom2.30 SMA201.68% SMA504.51% SMA20025.33% Volume4,207,657 Change-1.23%
Oct-09-18Initiated Guggenheim Buy
Oct-01-18Reiterated SunTrust Buy $105 → $123
Sep-26-18Resumed JP Morgan Overweight $117
Jul-25-18Downgrade Berenberg Buy → Hold
Jun-08-18Initiated Cantor Fitzgerald Overweight $100
Apr-13-18Upgrade BMO Capital Markets Underperform → Market Perform $74 → $79
Jan-22-18Downgrade Credit Suisse Neutral → Underperform
Jan-16-18Downgrade Goldman Buy → Neutral
Jan-05-18Upgrade Argus Hold → Buy
Oct-10-17Downgrade Credit Suisse Outperform → Neutral
Jul-26-17Downgrade Leerink Partners Outperform → Mkt Perform
Apr-27-17Downgrade Argus Buy → Hold
Apr-17-17Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-07-17Reiterated Barclays Overweight $85 → $90
Mar-20-17Reiterated UBS Neutral $70 → $85
Dec-16-16Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-27-16Upgrade Goldman Neutral → Buy
Sep-08-16Upgrade JP Morgan Neutral → Overweight
May-02-16Reiterated Leerink Partners Outperform $96 → $101
Apr-06-16Initiated Societe Generale Hold $78
Oct-19-18 06:49PM  Cramer's lightning round: GoPro's stock could go higher on a 'good holiday season' CNBC
09:30AM  BMY vs. LLY: Which Stock Should Value Investors Buy Now? Zacks
Oct-18-18 12:24PM  Better Buy: GlaxoSmithKline plc vs. Eli Lilly Motley Fool
Oct-17-18 01:59PM  Exclusive: Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva Reuters
01:38PM  Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva Reuters
11:25AM  Stocks - Netflix Soars in Pre-market; IBM, Tilray, Canopy Growth Sink; Tesla Rises Investing.com
06:00AM  5 Blue Chip Drug Stocks Poised for Long-Term Gains Investopedia
Oct-16-18 05:10PM  Minnesota accuses insulin makers of deceptive drug pricing Reuters
03:48PM  AstraZeneca's (AZN) Lynparza Gets Another Orphan Drug Status Zacks
03:21PM  Minnesota accuses insulin makers of deceptive drug pricing Reuters
06:45AM  Karen Walker Elected to Lilly Board of Directors PR Newswire
Oct-15-18 01:57PM  Lilly Declares Fourth-Quarter 2018 Dividend PR Newswire
12:09PM  3 Healthcare Stocks to Buy Amid the Carnage InvestorPlace
11:23AM  Eli Lillys IPO of Animal Health Company Is Getting Ahead of Itself, Goldman Says Bloomberg
11:16AM  Drugmakers will soon talk about price in ads but not as explicitly as Trump administration wants CNBC
06:45AM  New Data Showcasing Lilly's Growing Commitment in Rheumatology to be Featured at the ACR/ARHP Annual Meeting PR Newswire
Oct-12-18 10:12AM  3 Large-Cap Pharma Stocks Performing Better Than Industry Zacks
09:30AM  Has Eli Lilly and (LLY) Outpaced Other Medical Stocks This Year? Zacks
09:15AM  This is Why Eli Lilly (LLY) is a Great Dividend Stock Zacks
06:45AM  Lilly and Metastatic Breast Cancer Advocates Launch Thriver Movement to Elevate Understanding of the Daily Impact of the Disease, Encourage Public to do More for MBC PR Newswire
Oct-11-18 06:48AM  Heres why you should expect more beats during this earnings season MarketWatch
Oct-10-18 07:56AM  The Daily Biotech Pulse: Novartis Blood Disorder Drug Improves Patient Outcomes, Audentes To Offer Shares Benzinga
06:30AM  New analysis estimates the positive impact of Jardiance® on life expectancy in adults with type 2 diabetes and established cardiovascular disease PR Newswire
Oct-09-18 05:02PM  Lilly's Investigational Dual GIP and GLP-1 Receptor Agonist Shows Significant Reduction in HbA1c and Body Weight in People With Type 2 Diabetes CNW Group
04:11PM  4 Reasons to Be Wary of This Animal Health IPO Motley Fool
12:56PM  5 Companies Hit 52-Week Highs GuruFocus.com
Oct-08-18 06:05PM  Lilly to Present New Data From Oncology Portfolio at ESMO 2018 Congress, Showcasing Patient-Centric Advances in Cancer Care PR Newswire
11:15AM  Is Franklin LibertyQ U.S. Equity ETF (FLQL) a Hot ETF Right Now? Zacks
Oct-07-18 10:02AM  These Fundamentals Make Eli Lilly and Company (NYSE:LLY) Truly Worth Looking At Simply Wall St.
Oct-05-18 07:16PM  Cramer Remix: How this drug stock put the bear case to re... CNBC Videos
05:30PM  Market Winners & Losers Yahoo Finance Video
03:46PM  Eli Lilly Stock Is Climbing on Upbeat Drug Data and an Upgrade Barrons.com
03:02PM  Stocks Today: Tesla, Costco Hit As Nasdaq Extends Losses; 10-Year Yield Up Again Investor's Business Daily
10:13AM  Company News For Oct 5, 2018 Zacks
09:57AM  Pharma Stock Roundup: PFE to Get New CEO, LLY Presents Impressive Diabetes Data Zacks
09:54AM  Lilly's Novel Diabetes Candidate Shows Promise in Phase II Zacks
09:43AM  Stocks Mixed On Jobs Report, Trade Data: China's Lenovo Takes A Dive Investor's Business Daily
08:35AM  The Daily Biotech Pulse: MediciNova Gets Orphan-Drug Status, KemPharm To Offer Shares, Emergent Buys Vaccine Maker Benzinga
08:00AM  Today's Research Reports on Trending Tickers: Eli Lilly and Company and Mallinckrodt ACCESSWIRE
07:40AM  3 Big Stock Charts for Friday: PPL, Macys and Eli Lilly InvestorPlace
Oct-04-18 04:44PM  Alphabet and Simon Property skid while Constellation rises Associated Press
03:45PM  Tech Stocks Punished As Nasdaq Breaks Support; Leading Software Stocks Nailed Investor's Business Daily
12:12PM  US STOCKS-Wall St succumbs to soaring bond yields Reuters
11:15AM  Boehringer Ingelheim and Lilly present full results of Tradjenta®'s CARMELINA® cardiovascular outcome trial PR Newswire
10:23AM  US STOCKS-Wall St succumbs to soaring bond yields Reuters
09:55AM  Lilly's diabetes drug data impresses, hurts rival Novo's shares Reuters
09:01AM  US STOCKS-Wall St set to open lower as Treasury yields jump Reuters
08:57AM  Diabetes Drug's Results Push Lilly to Look at Obesity Too Bloomberg
07:59AM  The Daily Biotech Pulse: AtriCure's Guidance, Guardant Health And Kodiak To Debut Benzinga
07:36AM  Eli Lilly's stock surges toward record after positive trials for diabetes treatments MarketWatch
06:37AM  Global Markets Drag Stocks Lower; Did China Hack Apple? Investor's Business Daily
06:30AM  Boehringer Ingelheim and Lilly present full results from EASE Phase III program for empagliflozin as adjunct to insulin in type 1 diabetes PR Newswire
06:00AM  Lilly's Investigational Dual GIP and GLP-1 Receptor Agonist Shows Significant Reduction in HbA1c and Body Weight in People With Type 2 Diabetes PR Newswire
06:00AM  Eli Lilly's diabetes drug shows promise in mid-stage trial Reuters
Oct-03-18 03:00PM  Lilly Confirms Date and Conference Call for Third-Quarter 2018 Financial Results Announcement PR Newswire
11:28AM  Eli Lilly's Ultra Rapid Lispro Succeeds in Diabetes Studies Zacks
09:26AM  The hidden dangers of testosterone replacement therapy you should know about CNBC
07:54AM  The Daily Biotech Pulse: Endologix's Q3 Sales, Obseva's Positive Trial Results, Kala To Offer Shares Benzinga
Oct-02-18 09:00AM  Migraine sufferers: Help is on the way from 3 new drugs, but theyll cost $6,900 a year MarketWatch
07:37AM  Stocks making the biggest move premarket: PEP, AMZN, SFIX, CVX & more CNBC
06:27AM  Eli Lilly's diabetes treatment meets main goal in two late-stage studies Reuters
06:00AM  Results from Two Phase 3 Studies Show Lilly's Ultra Rapid Lispro (URLi) Met Primary Efficacy Endpoint in People with Type 1 and Type 2 Diabetes PR Newswire
Oct-01-18 01:44PM  Do You Know Who Else Invests In Eli Lilly and Company (NYSE:LLY)? Simply Wall St.
07:46AM  The Zacks Analyst Blog Highlights: Alphabet, Bank of America, PepsiCo, Eli Lilly and Intuitive Surgical Zacks
Sep-30-18 08:44AM  Better Buy: AbbVie Inc. vs. Eli Lilly and Company Motley Fool
05:00AM  People Treat Animals Like Parts of Their Family. Henry Schein Is Spinning Off Its Pet-Health Business Barrons.com
Sep-28-18 07:30PM  Tesla and More Mark End of Quarte; FDA OKs Lilly's Migraine Drug -- ICYMI TheStreet.com
05:53PM  Winners and losers for Friday, September 28th Yahoo Finance Video
01:58PM  Eli Lilly's FDA-Approved Migraine Drug is Welcomed by the 38 Million Sufferers TheStreet.com
11:30AM  Stocks - Tesla Tumbles in Pre-market; Eli Lilly, BlackBerry Gain Investing.com
11:24AM  Eli Lilly (LLY) Gets FDA Nod for Migraine Drug Emgality Zacks
10:51AM  Lilly Bio-Medicines president on new Emgality migraine dr... CNBC Videos
10:49AM  Google CEO in DC, Eli Lilly gets green light, Boeing wins big Yahoo Finance
10:43AM  Top Research Reports for Alphabet, Bank of America & PepsiCo Zacks
10:27AM  Google CEO in DC, Eli Lilly gets green light, Boeing wins big Yahoo Finance Video
10:07AM  Pharma Stock Roundup: PFE, LLY Get Approval for New Drugs, Novartis to Cut Jobs Zacks
08:10AM  The Daily Biotech Pulse: FDA Nods For Adamis, Eli Lilly, Pfizer; Spero, Obseva Report Positive Trial Results Benzinga
Sep-27-18 08:26PM  U.S. FDA approves Lilly migraine drug; price same as rivals Reuters
08:18PM  Eli Lilly Migraine Drug Approved and Will Be Free to Patients Bloomberg
08:01PM  U.S. FDA approves Lilly migraine drug; price same as rivals Reuters
07:52PM  Lilly's Emgality (galcanezumab-gnlm) Receives U.S. FDA Approval for the Preventive Treatment of Migraine in Adults PR Newswire
02:31PM  U.S. judge dismisses Teva lawsuits against Lilly on migraine drug Reuters
10:00AM  Here's Why Eli Lilly (LLY) is a Great Momentum Stock to Buy Zacks
09:03AM  Big Pharma Players on Strong Footing Ahead of Q4: 4 Picks Zacks
08:57AM  Trade of the Day: Eli Lilly (LLY) InvestorPlace
08:20AM  The Daily Biotech Pulse: Hologic Goes Shopping, Johnson & Johnson Snaps Ties With Geron Benzinga
Sep-26-18 07:00PM  Chugai and Lilly Enter into a License Agreement for Oral GLP-1 Agonist, OWL833 Business Wire
03:20PM  Novartis to Cut Over 2000 Jobs, Focus on Higher Value Drugs Zacks
01:19PM  JPMorgan Resumes Coverage Of Eli Lilly: 'One Of The Best-Positioned Names In Our Group' Benzinga
01:04PM  JP Morgan says buy Eli Lilly shares on its pipeline, predicts soaring profitability for drug maker CNBC
11:14AM  Glaxo's Tuberculosis Vaccine Positive in Mid-Stage Study Zacks
09:30AM  Is Eli Lilly and (LLY) Outperforming Other Medical Stocks This Year? Zacks
Sep-25-18 09:29AM  Elanco Animal Health IPO Motley Fool
08:33AM  A Brief Bird's Eye View of Fresh IPO Elanco Animal Health TheStreet.com
Sep-24-18 06:54PM  Cramer advises staying away from animal health play Elanc... CNBC Videos
06:43PM  Stay away from animal health play Elanco at these levels CNBC Videos
06:34PM  Cramer advises staying away from animal health play Elanco at these levels CNBC
05:51PM  J&J's Esketamine Fails to Meet Endpoint in Phase III Study Zacks
05:44PM  Newly Public Elanco Seeks to Innovate With Offering Proceeds TheStreet.com
05:36PM  Elanco Animal Health Incorporated Announces IPO Closing Business Wire
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. The company operates through two segments, Human Pharmaceutical Products and Animal Health Products. It offers endocrinology products for the treatment of diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and pediatric growth conditions. The company also provides neuroscience products for the treatment of depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; schizophrenia; attention-deficit hyperactivity disorder; obsessive-compulsive disorder, bulimia nervosa, and panic disorder; and positron emission tomography imaging of beta-amyloid neurotic plaques in adult brains, as well as immunology products to treat Alzheimer's disease. In addition, it offers oncology products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and cardiovascular products to treat erectile dysfunction and benign prostatic hyperplasia; and migraine. Further, the company provides animal health products, such as cattle feed additives; protein supplements for cows; leanness and performance enhancers for swine and cattle; antibiotics to treat respiratory and other diseases in cattle, swine, and poultry; anticoccidial agents for poultry use; and chewable tablets that kill fleas and prevent heartworm diseases. Additionally, it offers vaccines to prevent bordetella, Lyme disease, rabies, and parvovirus. The company has collaboration agreements with Daiichi Sankyo Co., Ltd.; Incyte Corporation; Pfizer Inc.; AstraZeneca; and Nektar Therapeutics, as well as has strategic collaboration with Sigilon Therapeutics. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LILLY ENDOWMENT INC10% OwnerOct 17Sale113.25174,69619,783,623119,005,804Oct 18 02:26 PM
LILLY ENDOWMENT INC10% OwnerOct 09Sale115.9110,6721,237,013119,180,500Oct 10 01:17 PM
LILLY ENDOWMENT INC10% OwnerOct 08Sale115.9114,6321,696,039119,191,172Oct 09 01:14 PM
LILLY ENDOWMENT INC10% OwnerOct 04Sale112.67116,03813,073,950119,205,804Oct 05 02:47 PM
Zulueta Alfonso GSVP & President, Lilly Int'lOct 04Sale114.647,000802,48045,224Oct 05 02:08 PM
LILLY ENDOWMENT INC10% OwnerOct 03Sale109.0178,9628,607,253119,321,842Oct 04 02:29 PM
LILLY ENDOWMENT INC10% OwnerSep 28Sale107.31107,55311,541,082119,400,804Oct 01 11:53 AM
LILLY ENDOWMENT INC10% OwnerSep 27Sale107.0092,4479,891,644119,508,357Sep 28 10:36 AM
LILLY ENDOWMENT INC10% OwnerSep 26Sale106.63134,41014,332,373119,600,804Sep 27 12:26 PM
LILLY ENDOWMENT INC10% OwnerSep 25Sale106.4155,5905,915,165119,735,214Sep 26 01:49 PM
LILLY ELI & CO10% OwnerSep 24Sale16.362,02733,1623,848,647Sep 26 02:50 PM
LILLY ELI & CO10% OwnerSep 18Sale14.566,870100,0273,850,674Sep 20 04:50 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 18Sale107.003,000321,00052,224Sep 19 05:47 PM
LILLY ELI & CO10% OwnerSep 17Sale14.586,865100,0923,857,544Sep 18 07:30 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 17Sale105.613,000316,83055,224Sep 19 05:47 PM
LILLY ELI & CO10% OwnerSep 14Sale14.589,009131,3513,864,409Sep 18 07:30 PM
LILLY ELI & CO10% OwnerSep 13Sale14.3220,900299,2883,873,418Sep 14 03:34 PM
LILLY ELI & CO10% OwnerSep 12Sale14.8310,059149,1753,894,318Sep 14 03:34 PM
LILLY ELI & CO10% OwnerSep 11Sale14.8711,277167,6893,904,377Sep 12 04:39 PM
LILLY ELI & CO10% OwnerSep 10Sale14.444,50064,9803,915,654Sep 12 04:39 PM
LILLY ENDOWMENT INC10% OwnerSep 07Sale106.76180,00019,217,055119,790,804Sep 10 12:44 PM
Zakrowski Donald AChief Accounting OfficerSep 04Sale105.5760063,3423,530Sep 04 04:50 PM
LILLY ELI & CO10% OwnerAug 31Sale14.267009,9823,920,154Sep 04 03:38 PM
LILLY ELI & CO10% OwnerAug 30Sale14.353,44049,3643,920,854Aug 31 12:40 PM
LILLY ENDOWMENT INC10% OwnerAug 30Sale105.42190,00020,030,370119,970,804Aug 31 09:07 AM
LILLY ELI & CO10% OwnerAug 29Sale14.262,31232,9693,924,294Aug 31 12:40 PM
LILLY ENDOWMENT INC10% OwnerAug 20Sale105.89195,00020,647,575120,160,804Aug 21 02:12 PM
LILLY ENDOWMENT INC10% OwnerAug 16Sale104.50200,00020,899,800120,355,804Aug 17 03:08 PM
LILLY ENDOWMENT INC10% OwnerAug 15Sale103.23151,79315,669,440120,555,804Aug 16 02:52 PM
LILLY ELI & CO10% OwnerAug 14Sale14.283,00042,8403,926,606Aug 16 03:34 PM
LILLY ELI & CO10% OwnerAug 13Sale14.334,53164,9293,929,606Aug 14 05:04 PM
LILLY ELI & CO10% OwnerAug 10Sale14.281,89827,1033,934,137Aug 14 05:04 PM
LILLY ENDOWMENT INC10% OwnerAug 10Sale103.063,587369,676120,707,597Aug 13 03:41 PM
LILLY ENDOWMENT INC10% OwnerAug 07Sale103.2224,6202,541,326120,711,184Aug 08 01:28 PM
LILLY ENDOWMENT INC10% OwnerAug 06Sale102.15195,00019,918,860120,735,804Aug 07 11:46 AM
LILLY ELI & CO10% OwnerAug 03Sale13.551,65022,3583,936,035Aug 07 03:16 PM
LILLY ELI & CO10% OwnerAug 02Sale13.3119,400258,2143,937,685Aug 03 03:53 PM
LILLY ENDOWMENT INC10% OwnerAug 02Sale99.58190,00018,919,939120,930,804Aug 03 02:31 PM
LILLY ENDOWMENT INC10% OwnerJul 31Sale98.74205,00020,240,873121,120,804Aug 01 01:12 PM
TAI JACKSON PDirectorJul 26Buy95.222,168206,43753,228Jul 27 10:46 AM
LILLY ENDOWMENT INC10% OwnerJul 25Sale94.73190,00017,999,259121,325,804Jul 26 02:17 PM
LILLY ENDOWMENT INC10% OwnerJul 24Sale92.03185,00017,025,985121,515,804Jul 25 11:47 AM
LILLY ENDOWMENT INC10% OwnerJul 06Sale87.44180,00015,738,300121,700,804Jul 09 10:45 AM
Pusey Leigh AnnSVP, Corp. Affairs & Comm.Jul 05Option Exercise0.002,39402,394Jul 09 11:58 AM
LILLY ENDOWMENT INC10% OwnerJul 05Sale86.62170,00014,725,740121,880,804Jul 06 11:13 AM
LILLY ENDOWMENT INC10% OwnerJun 15Sale86.65180,00015,597,720122,050,804Jun 18 12:39 PM
Skovronsky DanielSVP, CSO, and Pres. LRLJun 14Buy86.2210,000862,20055,199Jun 14 04:08 PM
LILLY ENDOWMENT INC10% OwnerJun 14Sale86.31107,6989,295,414122,230,804Jun 15 11:00 AM
LILLY ENDOWMENT INC10% OwnerJun 13Sale86.2711,104957,953122,338,502Jun 14 11:58 AM
LILLY ENDOWMENT INC10% OwnerJun 11Sale86.3851,1984,422,637122,349,606Jun 12 02:46 PM
LILLY ENDOWMENT INC10% OwnerJun 04Sale85.13135,47811,532,565122,400,804Jun 05 11:20 AM
LILLY ENDOWMENT INC10% OwnerJun 01Sale85.3139,5223,371,661122,536,282Jun 04 02:25 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAMay 31Sale85.0025,0002,125,000124,534Jun 01 04:22 PM
LILLY ENDOWMENT INC10% OwnerMay 30Sale83.85180,00015,092,640122,575,804May 31 01:18 PM
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 29Sale82.108,426691,7750May 31 01:05 PM
LILLY ENDOWMENT INC10% OwnerMay 11Sale81.97140,00011,475,940122,755,804May 14 02:29 PM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthMay 03Sale78.509,027708,620135,458May 03 04:34 PM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthMay 01Option Exercise0.0020,0000153,201May 03 04:34 PM
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 01Option Exercise0.0013,750013,750May 03 04:29 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAMay 01Option Exercise0.0020,0000158,468May 03 04:26 PM
LILLY ENDOWMENT INC10% OwnerApr 25Sale80.85180,00014,553,614122,895,804Apr 26 12:38 PM
Mahony SusanSVP & Pres., Lilly OncologyApr 16Sale80.0817,3791,391,71028,273Apr 17 03:29 PM
Mahony SusanSVP & Pres., Lilly OncologyApr 13Sale80.145,165413,92345,652Apr 17 03:29 PM
Smiley Joshua LSVP and CFOMar 16Sale79.203,000237,60020,029Mar 20 12:06 PM
Zakrowski Donald AChief Accounting OfficerMar 01Sale76.5086065,7901,637Mar 05 03:30 PM
Zakrowski Donald AChief Accounting OfficerFeb 21Sale77.5587667,9342,472Feb 23 05:42 PM
Norton JohnaSenior VP, Global QualityFeb 16Option Exercise0.0048048Feb 21 10:28 AM
Zakrowski Donald AChief Accounting OfficerFeb 05Sale81.0990072,9814,130Feb 05 06:39 PM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthFeb 05Sale81.129,625780,780133,201Feb 05 06:37 PM
O'Neill MylesSVP & Pres., Mfg. OperationsFeb 01Option Exercise0.009,596080,234Sep 24 04:45 PM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthFeb 01Option Exercise0.0021,3260152,120Feb 05 06:37 PM
Zulueta Alfonso GSVP & President, Lilly Int'lFeb 01Option Exercise0.0015,993065,357Feb 05 06:33 PM
Ricks David APresident & CEOFeb 01Option Exercise0.0021,3260140,809Feb 05 06:31 PM
Mahony SusanSVP & Pres., Lilly OncologyFeb 01Option Exercise0.0021,326060,350Feb 05 06:24 PM
Lundberg Jan MEVP,Science&Tech and Pres. LRLFeb 01Option Exercise0.0036,2520214,295Feb 05 06:21 PM
Harrington Michael JSenior VP and General CounselFeb 01Option Exercise0.0024,5240102,738Feb 05 06:19 PM
Fry Stephen FSVP, HR & DiversityFeb 01Option Exercise0.0017,0600107,820Feb 05 06:15 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAFeb 01Option Exercise0.0021,3260147,980Feb 05 06:12 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMFeb 01Option Exercise0.006,398022,107Feb 05 06:09 PM
LILLY ENDOWMENT INC10% OwnerDec 13Sale88.20200,00017,639,176123,075,804Dec 14 11:26 AM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthDec 11Sale86.4612,5001,080,750124,522Dec 13 03:01 PM
Zulueta Alfonso GSVP & President, Lilly Int'lDec 04Sale86.003,532303,75240,048Dec 05 05:35 PM
Mahony SusanSVP & Pres., Lilly OncologyDec 04Sale86.1836,5853,152,89554,885Dec 05 05:32 PM
Zakrowski Donald AChief Accounting OfficerDec 03Option Exercise0.003,28104,167Dec 05 05:48 PM
Fry Stephen FSVP, HR & DiversityDec 03Option Exercise0.007,557086,501Dec 05 05:46 PM
Ricks David APresident & CEODec 03Option Exercise0.005,4960110,059Dec 05 05:43 PM
Zulueta Alfonso GSVP & President, Lilly Int'lNov 10Sale83.672,003167,59143,580Nov 13 12:55 PM